Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-ADAR/IFI4 Antibody (R3N40)

Catalog #:   RHF11402 Specific References (50) DATASHEET
Host species: Mouse
Isotype: IgG1
Applications: ELISA, FCM, WB
Accession: P55265
Overview

Catalog No.

RHF11402

Species reactivity

Human

Host species

Mouse

Isotype

IgG1

Clonality

Monoclonal

Tested applications

ELISA: 1:10000, FCM: 1:200-1:400, WB: 1:500-1:2000

Target

Double-stranded RNA-specific adenosine deaminase, G1P1, IFI-4, ADAR, K88DSRBP, DRADA, ADAR1, IFI4, Interferon-inducible protein 4, p136, 136 kDa double-stranded RNA-binding protein, DSRAD

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% as determined by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P55265

Applications

ELISA, FCM, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% Sodium Azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.

Clone ID

R3N40

Data Image
  • Flow Cytometry
    Flow cytometric analysis of HeLa cells using ADAR mouse mAb (green) and negative control (red).
  • Western blot
    Western blot analysis using ADAR mouse mAb against Ramos (1), K562 (2), and Jurkat (3) cell lysate.
References

3'UTR RNA editing driven by ADAR1 modulates MDM2 expression in breast cancer cells., PMID:40381037

ADARp110 promotes hepatocellular carcinoma progression via stabilization of CD24 mRNA., PMID:39808660

Predicting graft survival in paediatric kidney transplant recipients using machine learning., PMID:39150523

Quantification of AMPA receptor subunits and RNA editing-related proteins in the J20 mouse model of Alzheimer's disease by capillary western blotting., PMID:38299128

Immunologic and Protective Properties of Subunit- vs. Whole Toxoid-Derived Anti-Botulinum Equine Antitoxin., PMID:36146601

IFN-I inducible miR-3614-5p targets ADAR1 isoforms and fine tunes innate immune activation., PMID:35935998

Single-cell RNA Sequencing Analysis Reveals New Immune Disorder Complexities in Hypersplenism., PMID:35865544

Adenosine-Deaminase-Acting-on-RNA-1 Facilitates T-cell Migration toward Human Melanoma Cells., PMID:35731225

Not "If", but "When" and "How": Testing Antibody-Drug Conjugates in Patients with Non-muscle-invasive Bladder Cancer., PMID:34838351

Evaluation of a downstream process for the recovery and concentration of a Cell-Culture-Derived rVSV-Spike COVID-19 vaccine candidate., PMID:34756612

Host Immune Response Driving SARS-CoV-2 Evolution., PMID:32992592

Clinical and serological features of dermatomyositis and systemic lupus erythematosus patients with autoantibodies to ADAR1., PMID:32907776

Host immune response driving SARS-CoV-2 evolution., PMID:32839723

RNA editing contributes to epitranscriptome diversity in chronic lymphocytic leukemia., PMID:32728184

MS2-TRIBE Evaluates Both Protein-RNA Interactions and Nuclear Organization of Transcription by RNA Editing., PMID:32674054

RNA editing as a therapeutic approach for retinal gene therapy requiring long coding sequences., PMID:31991730

Infectious vaccine-derived rubella viruses emerge, persist, and evolve in cutaneous granulomas of children with primary immunodeficiencies., PMID:31658304

RNA editing in the forefront of epitranscriptomics and human health., PMID:31547885

AKT-dependent phosphorylation of the adenosine deaminases ADAR-1 and -2 inhibits deaminase activity., PMID:31095429

Comparative safety and effectiveness of tumor necrosis factor α antagonists and vedolizumab in elderly IBD patients: a multicentre study., PMID:30773667

Illuminating spatial A-to-I RNA editing signatures within the Drosophila brain., PMID:30659150

APOBEC and ADAR deaminases may cause many single nucleotide polymorphisms curated in the OMIM database., PMID:29957488

ADAR1-mediated regulation of melanoma invasion., PMID:29855470

Integrative Analysis of Immunological Data to Explore Chronic Immune T-Cell Activation in Successfully Treated HIV Patients., PMID:28046052

REPLY: Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing., PMID:28003044

Treatment with oxLDL antibody reduces cathepsin S expression in atherosclerosis via down-regulating ADAR1-mediated RNA editing., PMID:27956316

Adenosine-to-inosine RNA editing controls cathepsin S expression in atherosclerosis by enabling HuR-mediated post-transcriptional regulation., PMID:27595325

TRIBE: Hijacking an RNA-Editing Enzyme to Identify Cell-Specific Targets of RNA-Binding Proteins., PMID:27040499

The Importance of Intestinal Eotaxin-1 in Inflammatory Bowel Disease: New Insights and Possible Therapeutic Implications., PMID:26874691

A Phase III Study of Balugrastim Versus Pegfilgrastim in Breast Cancer Patients Receiving Chemotherapy With Doxorubicin and Docetaxel., PMID:26668251

A novel immune resistance mechanism of melanoma cells controlled by the ADAR1 enzyme., PMID:26338962

Single nucleotide polymorphisms/haplotypes associated with multiple rubella-specific immune response outcomes post-MMR immunization in healthy children., PMID:26329766

Oral Administration of OKT3 MAb to Patients with NASH, Promotes Regulatory T-cell Induction, and Alleviates Insulin Resistance: Results of a Phase IIa Blinded Placebo-Controlled Trial., PMID:25876706

Stability of the parainfluenza virus 5 genome revealed by deep sequencing of strains isolated from different hosts and following passage in cell culture., PMID:24453358

Assessment of interferon-related biomarkers in Aicardi-Goutières syndrome associated with mutations in TREX1, RNASEH2A, RNASEH2B, RNASEH2C, SAMHD1, and ADAR: a case-control study., PMID:24183309

Oral administration of immunoglobulin G-enhanced colostrum alleviates insulin resistance and liver injury and is associated with alterations in natural killer T cells., PMID:22236001

Genetic polymorphisms in host antiviral genes: associations with humoral and cellular immunity to measles vaccine., PMID:21939710

Non-ST Elevation Myocardial Infraction after High Dose Intravenous Immunoglobulin Infusion., PMID:20182639

Cholestatic jaundice induced by atorvastatin: a possible association with antimitochondrial antibodies., PMID:19911499

Adalimumab-induced autoimmune hepatitis., PMID:19593165

A universal epitope-based influenza vaccine and its efficacy against H5N1., PMID:19356612

ADAR1 and ADAR2 expression and editing activity during forebrain development., PMID:19325227

Inversing the natural hydrogen bonding rule to selectively amplify GC-rich ADAR-edited RNAs., PMID:18515351

ICAM1 and VCAM1 polymorphisms, coronary artery calcium, and circulating levels of soluble ICAM-1: the multi-ethnic study of atherosclerosis (MESA)., PMID:18420209

A method to find tissue-specific novel sites of selective adenosine deamination., PMID:16257978

Identification of new targets of Drosophila pre-mRNA adenosine deaminase., PMID:15522950

Contribution of immunological memory to protective immunity conferred by a Bacillus anthracis protective antigen-based vaccine., PMID:15155654

Characterization and application of Raman labels for confocal Raman microspectroscopic detection of cellular proteins in single cells., PMID:14596828

Human combinatorial Fab library yielding specific and functional antibodies against the human fibroblast growth factor receptor 3., PMID:12842902

A model for the generation of multiple A to G transitions in the human respiratory syncytial virus genome: predicted RNA secondary structures as substrates for adenosine deaminases that act on RNA., PMID:12029160

Datasheet
$ 220
Product specifications
50 μg 220 100 μg 350

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-ADAR/IFI4 Antibody (R3N40) [RHF11402]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only